|
EP4132524A4
(en)
|
|
ORAL COMPOSITIONS OF AN MK2 PATHWAY INHIBITOR FOR THE TREATMENT OF IMMUNE DISEASES
|
|
CY1116034T1
(el)
|
|
2-ανιλινοβενζιμιδαζολο-6-καρβοξαμιδια ως αντι-φλεγμονωδεις παραγοντες
|
|
IL299762A
(en)
|
|
Useful preparations for the treatment of Charcot-Marietot disease
|
|
EA202092829A1
(ru)
|
|
Композиции тофацитиниба с контролируемым высвобождением
|
|
EP4337203A4
(en)
|
|
INHIBITORS OF THE MENIN-MLL INTERACTION
|
|
EP4126038A4
(en)
|
|
VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS
|
|
MX2017011978A
(es)
|
|
Analogos deuterados de etifoxina, sus derivados y usos de estos.
|
|
GB202010464D0
(en)
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
|
|
IL292682A
(en)
|
|
Formulation of x842 for oral administration
|
|
EP4342417A4
(en)
|
|
SOLID TYPE DENTAL ABUTMENT
|
|
EP4054378C0
(en)
|
|
HAIR TREATMENT PROCESS
|
|
EP4255494A4
(en)
|
|
STABLE ORAL CANNABIDIOL COMPOSITIONS
|
|
EP4531808A4
(en)
|
|
GASTRIC RESIDENCY MEDICATION INTENDED FOR ORAL ADMINISTRATION
|
|
TH25665U
(th)
|
|
องค์ประกอบผลิตภัณฑ์สำหรับการยับยั้งรอยโรคฟันพุ
|
|
TH25665Y
(th)
|
|
องค์ประกอบผลิตภัณฑ์สำหรับการยับยั้งรอยโรคฟันพุ
|
|
EP4159191A4
(en)
|
|
COSMETIC COMPOSITION
|
|
EP4341271A4
(en)
|
|
Compositions for treatment of neurodegenerative conditions
|
|
CR20240192A
(es)
|
|
Composiciones farmacéuticas de efruxifermina
|
|
GB2610009B
(en)
|
|
Stable compositions for the treatment of dental caries
|
|
HUE066812T2
(hu)
|
|
Az utidelone szilárd, orális készítménye
|
|
EP4272732A4
(en)
|
|
ORAL EFINACONAZOLE COMPOSITION
|
|
EP4395806C0
(en)
|
|
PROTEIN COMPOSITIONS FOR THE TREATMENT OF ORAL MUSCULITIS
|
|
EP4405469A4
(en)
|
|
COMPOSITIONS FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH DISEASE
|
|
IL307342A
(en)
|
|
Formulations of apremilast
|
|
EP4316452A4
(en)
|
|
POLYMERIZABLE DENTAL COMPOSITION
|